| Product Code: ETC9967704 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Herpes Zoster Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Herpes Zoster Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Herpes Zoster Market - Industry Life Cycle |
3.4 United States (US) Herpes Zoster Market - Porter's Five Forces |
3.5 United States (US) Herpes Zoster Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Herpes Zoster Market Revenues & Volume Share, By Treatment and Prevention, 2021 & 2031F |
3.7 United States (US) Herpes Zoster Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Herpes Zoster Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Herpes Zoster Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about herpes zoster vaccination |
4.2.2 Growing geriatric population in the United States |
4.2.3 Rise in the prevalence of herpes zoster cases |
4.3 Market Restraints |
4.3.1 High cost associated with herpes zoster vaccines |
4.3.2 Limited access to healthcare services for certain population segments |
4.3.3 Potential side effects or concerns regarding the safety of vaccines |
5 United States (US) Herpes Zoster Market Trends |
6 United States (US) Herpes Zoster Market, By Types |
6.1 United States (US) Herpes Zoster Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Herpes Zoster Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Herpes Zoster Market Revenues & Volume, By Laboratory Testing, 2021- 2031F |
6.1.4 United States (US) Herpes Zoster Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Herpes Zoster Market, By Treatment and Prevention |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Herpes Zoster Market Revenues & Volume, By Antiviral Medications, 2021- 2031F |
6.2.3 United States (US) Herpes Zoster Market Revenues & Volume, By Narcotic Medications, 2021- 2031F |
6.2.4 United States (US) Herpes Zoster Market Revenues & Volume, By Anti-Inflammatory Medications, 2021- 2031F |
6.2.5 United States (US) Herpes Zoster Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.2.6 United States (US) Herpes Zoster Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.7 United States (US) Herpes Zoster Market Revenues & Volume, By Capsaicin, 2021- 2031F |
6.2.8 United States (US) Herpes Zoster Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 United States (US) Herpes Zoster Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Herpes Zoster Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Herpes Zoster Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Herpes Zoster Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 United States (US) Herpes Zoster Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Herpes Zoster Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Herpes Zoster Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.3 United States (US) Herpes Zoster Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.4 United States (US) Herpes Zoster Market Revenues & Volume, By Research & Academic Institutes, 2021- 2031F |
6.4.5 United States (US) Herpes Zoster Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.4.6 United States (US) Herpes Zoster Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Herpes Zoster Market Import-Export Trade Statistics |
7.1 United States (US) Herpes Zoster Market Export to Major Countries |
7.2 United States (US) Herpes Zoster Market Imports from Major Countries |
8 United States (US) Herpes Zoster Market Key Performance Indicators |
8.1 Rate of herpes zoster vaccination coverage among target population |
8.2 Number of new herpes zoster cases reported annually |
8.3 Healthcare provider recommendations for herpes zoster vaccination |
8.4 Patient adherence to herpes zoster vaccination schedule |
8.5 Public health campaigns effectiveness in promoting herpes zoster vaccination |
9 United States (US) Herpes Zoster Market - Opportunity Assessment |
9.1 United States (US) Herpes Zoster Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Herpes Zoster Market Opportunity Assessment, By Treatment and Prevention, 2021 & 2031F |
9.3 United States (US) Herpes Zoster Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Herpes Zoster Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Herpes Zoster Market - Competitive Landscape |
10.1 United States (US) Herpes Zoster Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Herpes Zoster Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here